163 related articles for article (PubMed ID: 33740285)
1. Berberine ameliorates neuronal AD-like change via activating Pi3k/PGCε pathway.
Wu N; Liu W; Wang J; Han Y; Ye Y; Liu X; Yu Y; Chen Q; Bao Y; Liu C
Biofactors; 2021 Jul; 47(4):587-599. PubMed ID: 33740285
[TBL] [Abstract][Full Text] [Related]
2. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
[TBL] [Abstract][Full Text] [Related]
3. Effects of Berberine on Diabetes and Cognitive Impairment in an Animal Model: The Mechanisms of Action.
Zhang JH; Zhang JF; Song J; Bai Y; Deng L; Feng CP; Xu XY; Guo HX; Wang Y; Gao X; Gu Y; Jin C; Zheng JF; Zhen Z; Su H
Am J Chin Med; 2021; 49(6):1399-1415. PubMed ID: 34137676
[TBL] [Abstract][Full Text] [Related]
4. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P
Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane Prevents Neuronal Apoptosis and Memory Impairment in Diabetic Rats.
Wang G; Fang H; Zhen Y; Xu G; Tian J; Zhang Y; Zhang D; Zhang G; Xu J; Zhang Z; Qiu M; Ma Y; Zhang H; Zhang X
Cell Physiol Biochem; 2016; 39(3):901-7. PubMed ID: 27497670
[TBL] [Abstract][Full Text] [Related]
6. Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway.
Wang S; He B; Hang W; Wu N; Xia L; Wang X; Zhang Q; Zhou X; Feng Z; Chen Q; Chen J
J Alzheimers Dis; 2018; 65(4):1385-1400. PubMed ID: 30175975
[TBL] [Abstract][Full Text] [Related]
7. siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer's Disease Pathology: Evidence from
Gupta S; Singh V; Ganesh S; Singhal NK; Sandhir R
ACS Appl Mater Interfaces; 2022 Jan; 14(1):69-93. PubMed ID: 34967205
[TBL] [Abstract][Full Text] [Related]
8. Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats.
Chen Q; Mo R; Wu N; Zou X; Shi C; Gong J; Li J; Fang K; Wang D; Yang D; Wang K; Chen J
Front Pharmacol; 2017; 8():334. PubMed ID: 28634451
[No Abstract] [Full Text] [Related]
9. Berberine Improves Inflammatory Responses of Diabetes Mellitus in Zucker Diabetic Fatty Rats and Insulin-Resistant HepG2 Cells through the PPM1B Pathway.
Wu YS; Li ZM; Chen YT; Dai SJ; Zhou XJ; Yang YX; Lou JS; Ji LT; Bao YT; Xuan L; Lin LN; Li CY
J Immunol Res; 2020; 2020():2141508. PubMed ID: 32908938
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone ameliorates Aβ42 deposition in rats with diet-induced insulin resistance associated with AKT/GSK3β activation.
Yang S; Chen Z; Cao M; Li R; Wang Z; Zhang M
Mol Med Rep; 2017 May; 15(5):2588-2594. PubMed ID: 28447730
[TBL] [Abstract][Full Text] [Related]
11. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
[TBL] [Abstract][Full Text] [Related]
12. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
Gupta A; Bisht B; Dey CS
Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
[TBL] [Abstract][Full Text] [Related]
13. A SIRT1 agonist reduces cognitive decline in type 2 diabetic rats through antioxidative and anti‑inflammatory mechanisms.
Wang F; Shang Y; Zhang R; Gao X; Zeng Q
Mol Med Rep; 2019 Feb; 19(2):1040-1048. PubMed ID: 30483738
[TBL] [Abstract][Full Text] [Related]
14. Electroacupuncture improves cognitive deficits and insulin resistance in an OLETF rat model of Al/D-gal induced aging model via the PI3K/Akt signaling pathway.
Huang X; Huang K; Li Z; Bai D; Hao Y; Wu Q; Yi W; Xu N; Pan Y; Zhang L
Brain Res; 2020 Aug; 1740():146834. PubMed ID: 32304687
[TBL] [Abstract][Full Text] [Related]
15. Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice.
Babic Perhoc A; Osmanovic Barilar J; Knezovic A; Farkas V; Bagaric R; Svarc A; Grünblatt E; Riederer P; Salkovic-Petrisic M
Neuropharmacology; 2019 Apr; 148():50-67. PubMed ID: 30571958
[TBL] [Abstract][Full Text] [Related]
16. Berberine Ameliorates Cognitive Disorder via GSK3β/PGC-1α Signaling in APP/PS1 Mice.
Yang M; Wang J
J Nutr Sci Vitaminol (Tokyo); 2022; 68(3):228-235. PubMed ID: 35768254
[TBL] [Abstract][Full Text] [Related]
17. Platycodin D Ameliorates Cognitive Impairment in Type 2 Diabetes Mellitus Mice via Regulating PI3K/Akt/GSK3β Signaling Pathway.
Lu YW; Xie LY; Qi MH; Ren S; Wang YQ; Hu JN; Wang Z; Tang S; Zhang JT; Li W
J Agric Food Chem; 2024 Jun; 72(22):12516-12528. PubMed ID: 38491972
[No Abstract] [Full Text] [Related]
18. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
[TBL] [Abstract][Full Text] [Related]
19. Eugenosedin-A improves glucose metabolism and inhibits MAPKs expression in streptozotocin/nicotinamide-induced diabetic rats.
Shen KP; Lin HL; Yen HW; Hsieh SL; An LM; Wu BN
Kaohsiung J Med Sci; 2018 Mar; 34(3):142-149. PubMed ID: 29475461
[TBL] [Abstract][Full Text] [Related]
20. The protective effect of formononetin on cognitive impairment in streptozotocin (STZ)-induced diabetic mice.
Wang J; Wang L; Zhou J; Qin A; Chen Z
Biomed Pharmacother; 2018 Oct; 106():1250-1257. PubMed ID: 30119194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
